Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022
May 03 2022 - 8:03AM
Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop
synthetic biology systems, today announced that it will release its
first quarter 2022 financial results on Tuesday, May 10, 2022,
after the market closes. In conjunction with the release,
management will host a conference call on Tuesday, May 10, 2022, at
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the
financial results and recent corporate highlights.
The press release and live audio webcast can be accessed via the
Investor section of the Company’s website at www.codexdna.com. The
conference call can be accessed by dialing (888) 705-0127
(domestic) or (409) 937-8880 (international) and referring to
conference ID 7942349. Please log in approximately 5 to 10 minutes
before the event to ensure a timely connection. The archived
webcast will remain available for replay on Codex DNA’s website for
30 days.
About Codex DNA
Codex DNA is empowering scientists with the ability to create
sustainable, synthetic biology solutions for many of humanity’s
greatest challenges. As inventors of the industry-standard Gibson
Assembly® method and the first commercial automated benchtop DNA
and mRNA synthesis system, Codex DNA is enabling rapid, accurate,
and reproducible writing of DNA and mRNA for numerous downstream
markets. The company’s award-winning BioXp™ system consolidates,
automates, and optimizes the entire synthesis, cloning, and
amplification workflow. As a result, it delivers virtually
error-free synthesis of DNA/RNA at scale within days and hours
instead of weeks or months. Scientists around the world are using
the technology in their own laboratories to accelerate the
design-build-test paradigm for novel, high-value products for
precision medicine, biologics drug discovery, vaccine and
therapeutic development, genome editing, and cell and gene therapy.
Codex DNA is a public company based in San Diego. For more
information, visit codexdna.com.Contact:Richard
LepkeDirector of Investor Relations(619)
840-5392RichardL@codexdna.com
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codex DNA (NASDAQ:DNAY)
Historical Stock Chart
From Jul 2023 to Jul 2024